Division of Pediatric Nephrology, Children's Hospital at Montefiore, Bronx, NY.
Transplantation. 2020 Mar;104(3):597-602. doi: 10.1097/TP.0000000000002827.
An elevated terminal creatinine is frequently used as a reason for organ refusal in pediatric kidney transplantation. There is increasing evidence that adults who receive kidneys from donors with moderate to severe acute kidney injury (AKI) have similar outcomes to recipients who receive kidneys from donors with none to mild AKI.
We used the Scientific Registry of Transplant Recipients to determine how many pediatric kidney transplant recipients developed delayed graft function (DGF) between 2000 and 2010.
When stratified by the donor terminal creatinine, there was no significant difference in the recipient discharge creatinine or the likelihood of developing DGF. In a logistic regression model, older donor age, male donors, and a longer cold ischemia time but not donor terminal creatinine were independent predictors of DGF. There were very few graft loss events documented in this study.
Our results are in agreement with previously published data; a high donor terminal creatinine is not significantly associated with DGF in pediatric renal transplant recipients. Additional studies investigating the risk of rejection and long-term graft function are needed before adopting the practice of accepting kidneys with moderate to severe AKI in pediatric kidney transplant recipients.
在儿科肾移植中,终末期肌酐升高常被作为拒绝器官的原因。越来越多的证据表明,接受来自中重度急性肾损伤(AKI)供体的肾脏的成年人与接受来自无至轻度 AKI 供体的肾脏的接受者具有相似的结果。
我们使用移植受者科学登记处来确定 2000 年至 2010 年间有多少儿科肾移植受者发生了延迟移植物功能(DGF)。
按供体终末期肌酐分层,受者出院肌酐或发生 DGF 的可能性没有差异。在逻辑回归模型中,供体年龄较大、男性供体和冷缺血时间较长但不是供体终末期肌酐是 DGF 的独立预测因素。本研究中记录的移植物丢失事件很少。
我们的结果与先前发表的数据一致;高供体终末期肌酐与儿科肾移植受者的 DGF 无显著相关性。在接受中度至重度 AKI 的供体肾脏之前,需要进一步研究排斥反应和长期移植物功能的风险。